Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype

PURPOSE: Triple negative breast cancer (TNBC) is an aggressive clinical tumor, accounting for about 25% of breast cancer (BC) related deaths. Chemotherapy is the only therapeutic option to treat TNBC, hence a detailed understanding of the biology and its categorization is required. To investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Angius, Andrea, Pira, Giovanna, Cossu-Rocca, Paolo, Sotgiu, Giovanni, Saderi, Laura, Muroni, Maria Rosaria, Virdis, Patrizia, Piras, Daniela, Vincenzo, Rallo, Carru, Ciriaco, Coradduzza, Donatella, Uras, Maria Gabriela, Cottu, Pierina, Fancellu, Alessandro, Orrù, Sandra, Uva, Paolo, De Miglio, Maria Rosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314865/
https://www.ncbi.nlm.nih.gov/pubmed/36030436
http://dx.doi.org/10.1007/s00432-022-04301-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314865/
https://www.ncbi.nlm.nih.gov/pubmed/36030436
http://dx.doi.org/10.1007/s00432-022-04301-w

Ejemplares similares